Projects per year
Personal profile
Fingerprint
- 1 Similar Profiles
Most recent collaborations and top research areas
Projects
- 2 Finished
-
SynNotch: Identifying the hematopoietic and leukemic stem cell niches.
Reinisch, A. (Principal investigator), Sconocchia, T. (Co-investigator), Auinger, L. (Co-investigator), Foßelteder, J. (Co-investigator), Pabst, G. (Co-investigator), Özkaya, E. (Co-investigator), Alihodzic, D. (Co-investigator) & Schlacher, A. (Co-investigator)
1/01/21 → 30/06/25
Project: Research funding
-
CRISPR/Cas9 genome engineering to dissect MPN pathogenesis
Reinisch, A. (Principal investigator), Nieß, S. (Co-investigator), Pabst, G. (Co-investigator), Özkaya, E. (Co-investigator) & Schlacher, A. (Co-investigator)
7/01/20 → 6/07/24
Project: Research funding
Research output
- 1 Research article
-
Engineered cytokine-expressing MSCs support ex vivo culture of human HSPCs and AML cells.
Foßelteder, J. (First author), Brauchart, T., Schlacher, A., Sconocchia, T., Özkaya, E., Auinger, L., Schlenke, P., Sill, H., Zebisch, A. & Reinisch, A. (Last author), Jul 2025, In: Experimental Hematology. 147, p. 104790 7 p., 104790.Research output: Contribution to journal › Research article
1 Citation (Web of Science)
-
Modeling TP53 mutation-driven human clonal hematopoiesis and leukemogenesis
Foßelteder, J. (Speaker), Raicht, A. (Author), Özkaya, E. (Author), Alihodzic, D. (Author), Dorset, S. R. (Author), Kashofer, K. (Author), Schlenke, P. (Author), Bak, R. O. (Author), Zebisch, A. (Author), Sill, H. (Author) & Reinisch, A. (Author)
2026Activity: Talk, presentation or poster › Poster
-
CRISPR/CAS9 genome engineering to model TET2 mutant myeloid effector cells and its pro-atherogenic potential.
Alihodzic, D. (Author), Özkaya, E. (Author), Foßelteder, J. (Author), Sconocchia, T. (Author), Auinger, L. (Author), Schlenke, P. (Author), Sill, H. (Author), Zebisch, A. (Author), Wölfler, A. (Author), Vujic, N. (Author), Kratky, D. (Author) & Reinisch, A. (Author)
2025Activity: Talk, presentation or poster › Scientific talk or presentation › On site
-
Investigating the contribution of TET2 mutant human clonal hematopoiesis to human atherosclerotic plaque formation in a novel LDLR/ApoE double knock-out mouse model.
Alihodzic, D. (Speaker), Özkaya, E. (Author), Foßelteder, J. (Author), Sconocchia, T. (Author), Auinger, L. (Author), Schlenke, P. (Author), Sill, H. (Author), Zebisch, A. (Author), Wölfler, A. (Author), Vujic, N. (Author), Kratky, D. (Author) & Reinisch, A. (Author)
2024Activity: Talk, presentation or poster › Poster
-
Genome engineered TET2 loss-of-function mutations increase stem cell self-renewal in human hematopoietic stem and progenitor cells.
Özkaya, E. (Speaker), Sconocchia, T. (Author), Foßelteder, J. (Author), Alihodzic, D. (Author), Schlacher, A. (Author), Auinger, L. (Author), Schlenke, P. (Author), Sill, H. (Author), Zebisch, A. (Author) & Reinisch, A. (Author)
2024Activity: Talk, presentation or poster › Poster
-
Modeling SRSF2/TET2 mutational cooperativity in CMML development
Alihodzic, D. (Speaker), Özkaya, E. (Author), Pabst, G. (Author), Foßelteder, J. (Author), Sconocchia, T. (Author), Auinger, L. (Author), Schlenke, P. (Author), Sill, H. (Author), Zebisch, A. (Author), Wölfler, A. (Author) & Reinisch, A. (Author)
2024Activity: Talk, presentation or poster › Poster